B. Cherouny
7 Papers
1 Citations
B. Cherouny is an academic researcher. The author has contributed to research in topics: Transthyretin & Internal medicine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
René Rettl,Tim Wollenweber,Franz Duca,Christina Binder,B. Cherouny,Theresa-Marie Dachs,Camuz Ligios Luciana,Lore Schrutka,Daniel Dalos,Dietrich Beitzke,Christian Loewe,Roza Badr Eslam,Johannes Kastner,Marcus Hacker,Diana Bonderman +14 more
TL;DR: In this article , the authors investigated the relationship between treatment response and cardiac amyloid burden identified by serial quantitative 99mTc-DPD SPECT/CT imaging and identified nuclear imaging biomarkers that could be used to quantify and monitor response to tafamidis therapy.
30
Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy
René Rettl,Franz Duca,Christina Binder,Theresa-Marie Dachs,B. Cherouny,Luciana Camuz Ligios,Christopher Mann,Lore Schrutka,Daniel Dalos,Silvia Charwat-Resl,Roza Badr Eslam,Johannes Kastner,Diana Bonderman +12 more
TL;DR: Treatment with tafamidis free acid 61 mg in ATTR-CM patients delays the deterioration of LA and LV longitudinal function, resulting in significant clinical benefits compared with natural history.
15
Myocardial structural and functional changes in cardiac amyloidosis - Insights from a prospective observational patient registry.
Franz Duca,René Rettl,Christina Kronberger,Christina Binder,Christopher Mann,Fabian Dusik,Lore Schrutka,Daniel Dalos,Begüm Öztürk,Theresa-Marie Dachs,B. Cherouny,Luciana Camuz Ligios,Hermine Agis,Renate Kain,Matthias Koschutnik,Carolina Doña,R Badr-Eslam,Johannes Kastner,Dietrich Beitzke,Christian Loewe,Christian Nitsche,Christian Hengstenberg,Andreas A. Kammerlander,Diana Bonderman +23 more
TL;DR: The present study supports the use of serial ECV quantification in CA patients, as change of ECV was a predictor of outcome and could provide information in the evaluation of amyloid-specific treatments.
7
Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study
Nicolas Verheyen,M. Ungericht,Lisa Paar,Kathrin Danninger,Stefanie Schneiderbauer-Porod,Franz Duca,B. Cherouny,Viktoria Hoeller,Klemens Ablasser,David Zach,Ewald Kolesnik,Daniel Kiblboeck,Matthias Frick,Diana Bonderman,Josef Dierneder,Christian Ebner,Thomas Weber,Gerhard Pölzl +17 more
TL;DR: The data underscore that tissue biopsy and histopathological analysis should be performed in every patient with suspected amyloidosis and monoclonal gammopathy even in case of Perugini Score II or III.
Two-dimensional speckle-tracking echocardiography in tafamidis-treated patients with transthyretin amyloid cardiomyopathy: a glimmer of hope for viable therapy monitoring?
René Rettl,Franz Duca,Christoph J. Binder,Theresa-Marie Dachs,B. Cherouny,Luciana Camuz Ligios,Carolin Mann,Lore Schrutka,Daniel Dalos,Silvia Charwat-Resl,Roza Badr Eslam,Johannes Kastner,Diana Bonderman +12 more
TL;DR: Treatment with Tafamidis 61mg in ATTR-CM patients delays the increase in IVS thickness and the deterioration of LA and LV longitudinal function, resulting in significant clinical benefits compared with natural history.